S02 E19: Medical affairs evolution and the future for MSLs

In this week’s episode, the GOLD team is joined by Luca Dezzani, Vice President, Oncology Medical Affairs, Johnson & Johnson. After first meeting Luca when he contributed to a GOLD article about the transition from medicine to medical affairs in 2021, we invited him to join us on the airwaves to delve further into his experience within the function, he discusses how the medical affairs function has evolved, the future of the MSL, his views on the metaverse and the power of cross-industry partnership.   If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:  The leap from medicine to medical affairs https://www.emg-gold.com/post/the-leap-from-medicine-to-medical-affairs  The reality of the metaverse https://www.emg-gold.com/post/the-reality-of-the-metaverse  Driving access to digital, gene therapies and rare disease education https://www.emg-gold.com/post/podcast-digital-solutions-cell-and-gene-therapy-and-haemophilia-in-focus  The progress and pain points of patient centricity https://www.emg-gold.com/post/the-progress-and-pain-points-of-patient-centricity 

There are no comments yet.

Please log in to write the first comment.